The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Wang Xiaodong since 2016.
This trader's CIK number is 1662982.
At the time of last reporting, Wang Xiaodong was the Director of Beone Medicines Ltd.. (stock ticker symbol ONC).
Also see all insider trading activities at Beone Medicines Ltd..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2025 | ONC | 0 | $0 | 260,713 | $60,857,750 | 250,560 | $1,628,640 |
2024 | ONC | 0 | $0 | 90,111 | $17,075,055 | 80,221 | $521,436 |
2023 | ONC | 0 | $0 | 67,635 | $15,257,982 | 67,635 | $8,792 |
2022 | ONC | 0 | $0 | 16,060 | $3,158,274 | 0 | $0 |
2021 | ONC | 0 | $0 | 12,394 | $4,179,508 | 47,503 | $6,175 |
2020 | ONC | 0 | $0 | 73,847 | $16,903,266 | 0 | $0 |
2019 | ONC | 0 | $0 | 19,847 | $3,509,783 | 0 | $0 |
2018 | ONC | 0 | $0 | 13,449 | $1,953,970 | 0 | $0 |
2017 | ONC | 0 | $0 | 200,000 | $8,628,249 | 0 | $0 |
2016 | ONC | 0 | $0 | 93,750 | $3,000,000 | 0 | $0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2025-06-24 | ONC | Sale | 2,007 | 265.81 | 533,474 |
2025-06-10 | ONC | Option Ex | 41,760 | 6.50 | 271,440 |
2025-06-10 | ONC | Sale | 41,760 | 263.10 | 10,987,139 |
2025-05-13 | BGNE | Option Ex | 41,760 | 6.50 | 271,440 |
2025-05-13 | BGNE | Sale | 41,760 | 224.06 | 9,356,703 |
2025-04-14 | BGNE | Option Ex | 41,760 | 6.50 | 271,440 |
2025-04-14 | BGNE | Sale | 41,760 | 243.52 | 10,169,562 |
2025-03-18 | BGNE | Sale | 41,760 | 261.12 | 10,904,371 |
2025-03-18 | BGNE | Option Ex | 41,760 | 6.50 | 271,440 |
2025-03-04 | BGNE | Sale | 8,146 | 254.67 | 2,074,549 |
2025-02-04 | BGNE | Option Ex | 41,760 | 6.50 | 271,440 |
2025-02-04 | BGNE | Sale | 41,760 | 225.64 | 9,422,726 |
2025-01-07 | BGNE | Option Ex | 41,760 | 6.50 | 271,440 |
2025-01-07 | BGNE | Sale | 41,760 | 177.42 | 7,409,226 |
2024-12-10 | BGNE | Option Ex | 41,760 | 6.50 | 271,440 |
2024-12-10 | BGNE | Sale | 41,760 | 189.29 | 7,904,708 |
2024-11-26 | BGNE | Option Ex | 38,461 | 6.50 | 249,996 |
2024-11-26 | BGNE | Sale | 48,351 | 189.66 | 9,170,347 |
2023-03-08 | BGNE | Option Ex | 67,635 | .13 | 8,792 |
2023-03-08 | BGNE | Sale | 67,635 | 225.59 | 15,257,982 |
2022-08-05 | BGNE | Sale | 10,000 | 193.35 | 1,933,470 |
2022-08-08 | BGNE | Sale | 6,060 | 202.11 | 1,224,804 |
2021-11-08 | BGNE | Sale | 4,500 | 350.47 | 1,577,128 |
2021-11-08 | BGNE | Sale | 4,500 | 351.11 | 1,580,013 |
2021-05-10 | BGNE | Sale | 3,394 | 301.23 | 1,022,367 |
2021-05-10 | BGNE | Option Ex | 47,503 | .13 | 6,175 |
2020-10-16 | BGNE | Sale | 5,000 | 320.00 | 1,600,000 |
2020-10-05 | BGNE | Sale | 5,000 | 300.00 | 1,500,000 |
2020-09-25 | BGNE | Sale | 5,000 | 280.82 | 1,404,095 |
2020-09-17 | BGNE | Sale | 5,000 | 260.69 | 1,303,454 |
2020-08-10 | BGNE | Sale | 4,000 | 212.35 | 849,396 |
2020-07-20 | BGNE | Sale | 17,000 | 251.50 | 4,275,517 |
2020-07-07 | BGNE | Sale | 6,000 | 200.00 | 1,200,000 |
2020-07-01 | BGNE | Sale | 4,847 | 190.83 | 924,962 |
2020-06-22 | BGNE | Sale | 5,000 | 181.95 | 909,745 |
2020-06-23 | BGNE | Sale | 6,000 | 186.52 | 1,119,108 |
2020-06-08 | BGNE | Sale | 6,000 | 171.46 | 1,028,730 |
2020-03-04 | BGNE | Sale | 5,000 | 157.65 | 788,259 |
2019-11-14 | BGNE | Sale | 11,109 | 193.98 | 2,154,901 |
2019-11-15 | BGNE | Sale | 1,891 | 202.05 | 382,076 |
2019-11-01 | BGNE | Sale | 1,000 | 170.00 | 170,000 |
2019-11-04 | BGNE | Sale | 1,000 | 190.00 | 190,000 |
2019-07-01 | BGNE | Sale | 4,847 | 126.43 | 612,806 |
2018-12-03 | BGNE | Sale | 5,000 | 155.71 | 778,545 |
2018-11-19 | BGNE | Sale | 5,000 | 124.58 | 622,875 |
2018-08-13 | BGNE | Sale | 3,449 | 160.21 | 552,550 |
2017-07-12 | BGNE | Sale | 20,000 | 72.49 | 1,449,740 |
2017-06-28 | BGNE | Sale | 35,000 | 45.17 | 1,581,090 |
2017-06-02 | BGNE | Sale | 5,539 | 40.00 | 221,560 |
2017-05-03 | BGNE | Sale | 9,970 | 40.71 | 405,868 |
2017-05-04 | BGNE | Sale | 4,491 | 41.01 | 184,171 |
2017-04-05 | BGNE | Sale | 11,650 | 36.80 | 428,766 |
2017-03-24 | BGNE | Sale | 18,787 | 36.93 | 693,841 |
2017-03-23 | BGNE | Sale | 11,041 | 36.99 | 408,461 |
2017-03-22 | BGNE | Sale | 8,279 | 37.75 | 312,515 |
2017-03-08 | BGNE | Sale | 10,992 | 39.77 | 437,206 |
2017-03-09 | BGNE | Sale | 18,596 | 39.95 | 742,835 |
2017-03-10 | BGNE | Sale | 7,304 | 39.94 | 291,699 |
2017-02-23 | BGNE | Sale | 5,505 | 38.57 | 212,349 |
2017-02-24 | BGNE | Sale | 28,402 | 38.34 | 1,088,819 |
2017-02-27 | BGNE | Sale | 4,444 | 38.10 | 169,329 |
2016-11-23 | BGNE | Sale | 93,750 | 32.00 | 3,000,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wang Xiaodong (Director of Beone Medicines Ltd. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.